The global market for Sterile Dosage Form was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to the "Global Use of Medicines 2023" released by the IQVIA Institute, the global drug expenditure in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and it is predicted that it will grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America, and Japan are expected to experience slower growth in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America, and Eastern Europe are expected to grow strongly. In terms of drug expenditure, China"s drug expenditure in 2022 will be about 166 billion US dollars. It is expected that the expenditure on medicines will only increase in the next few years: From the perspective of demand, the trend of population aging, the increase of residents" wealth and the improvement of health awareness will drive the demand for medicines;From the perspective of national strategy, in 2016, the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" was upgraded to a national strategy;From the perspective of industry policy, after experiencing the uncertainty brought about by the initial stage of medical reform, the implementation of the centralized procurement policy and the update of the drug reimbursement catalog will gradually achieve a dynamic balance of multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the masses.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sterile Dosage Form, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Dosage Form.
The Sterile Dosage Form market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sterile Dosage Form market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Dosage Form manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ten23 Health AG
DSM
VxP Pharma
Cambrex
Pharmaceutics International, Inc
Thermo Fisher Scientific
Curia Global
Dec Group
Grand River Aseptic Manufacturing
Segment by Type
Ophthalmic Preparations
Parenteral Preparations
Segment by Application
Clinical
Laboratory
Commercial
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sterile Dosage Form manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sterile Dosage Form in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Sterile Dosage Form 麻豆原创 Overview
1.1 Product Definition
1.2 Sterile Dosage Form by Type
1.2.1 Global Sterile Dosage Form 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Ophthalmic Preparations
1.2.3 Parenteral Preparations
1.3 Sterile Dosage Form by Application
1.3.1 Global Sterile Dosage Form 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Clinical
1.3.3 Laboratory
1.3.4 Commercial
1.3.5 Others
1.4 Global Sterile Dosage Form 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Sterile Dosage Form Revenue 2020-2031
1.4.2 Global Sterile Dosage Form Sales 2020-2031
1.4.3 Global Sterile Dosage Form 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sterile Dosage Form 麻豆原创 Competition by Manufacturers
2.1 Global Sterile Dosage Form Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Sterile Dosage Form Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Sterile Dosage Form Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sterile Dosage Form, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sterile Dosage Form, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sterile Dosage Form, Product Type & Application
2.7 Global Key Manufacturers of Sterile Dosage Form, Date of Enter into This Industry
2.8 Global Sterile Dosage Form 麻豆原创 Competitive Situation and Trends
2.8.1 Global Sterile Dosage Form 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Sterile Dosage Form Players 麻豆原创 Share by Revenue
2.8.3 Global Sterile Dosage Form 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sterile Dosage Form 麻豆原创 Scenario by Region
3.1 Global Sterile Dosage Form 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sterile Dosage Form Sales by Region: 2020-2031
3.2.1 Global Sterile Dosage Form Sales by Region: 2020-2025
3.2.2 Global Sterile Dosage Form Sales by Region: 2026-2031
3.3 Global Sterile Dosage Form Revenue by Region: 2020-2031
3.3.1 Global Sterile Dosage Form Revenue by Region: 2020-2025
3.3.2 Global Sterile Dosage Form Revenue by Region: 2026-2031
3.4 North America Sterile Dosage Form 麻豆原创 Facts & Figures by Country
3.4.1 North America Sterile Dosage Form 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sterile Dosage Form Sales by Country (2020-2031)
3.4.3 North America Sterile Dosage Form Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sterile Dosage Form 麻豆原创 Facts & Figures by Country
3.5.1 Europe Sterile Dosage Form 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sterile Dosage Form Sales by Country (2020-2031)
3.5.3 Europe Sterile Dosage Form Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sterile Dosage Form 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Sterile Dosage Form 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sterile Dosage Form Sales by Region (2020-2031)
3.6.3 Asia Pacific Sterile Dosage Form Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sterile Dosage Form 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Sterile Dosage Form 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sterile Dosage Form Sales by Country (2020-2031)
3.7.3 Latin America Sterile Dosage Form Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sterile Dosage Form 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Sterile Dosage Form 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sterile Dosage Form Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sterile Dosage Form Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sterile Dosage Form Sales by Type (2020-2031)
4.1.1 Global Sterile Dosage Form Sales by Type (2020-2025)
4.1.2 Global Sterile Dosage Form Sales by Type (2026-2031)
4.1.3 Global Sterile Dosage Form Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Sterile Dosage Form Revenue by Type (2020-2031)
4.2.1 Global Sterile Dosage Form Revenue by Type (2020-2025)
4.2.2 Global Sterile Dosage Form Revenue by Type (2026-2031)
4.2.3 Global Sterile Dosage Form Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Sterile Dosage Form Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sterile Dosage Form Sales by Application (2020-2031)
5.1.1 Global Sterile Dosage Form Sales by Application (2020-2025)
5.1.2 Global Sterile Dosage Form Sales by Application (2026-2031)
5.1.3 Global Sterile Dosage Form Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Sterile Dosage Form Revenue by Application (2020-2031)
5.2.1 Global Sterile Dosage Form Revenue by Application (2020-2025)
5.2.2 Global Sterile Dosage Form Revenue by Application (2026-2031)
5.2.3 Global Sterile Dosage Form Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Sterile Dosage Form Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ten23 Health AG
6.1.1 Ten23 Health AG Company Information
6.1.2 Ten23 Health AG Description and Business Overview
6.1.3 Ten23 Health AG Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ten23 Health AG Sterile Dosage Form Product Portfolio
6.1.5 Ten23 Health AG Recent Developments/Updates
6.2 DSM
6.2.1 DSM Company Information
6.2.2 DSM Description and Business Overview
6.2.3 DSM Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.2.4 DSM Sterile Dosage Form Product Portfolio
6.2.5 DSM Recent Developments/Updates
6.3 VxP Pharma
6.3.1 VxP Pharma Company Information
6.3.2 VxP Pharma Description and Business Overview
6.3.3 VxP Pharma Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.3.4 VxP Pharma Sterile Dosage Form Product Portfolio
6.3.5 VxP Pharma Recent Developments/Updates
6.4 Cambrex
6.4.1 Cambrex Company Information
6.4.2 Cambrex Description and Business Overview
6.4.3 Cambrex Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cambrex Sterile Dosage Form Product Portfolio
6.4.5 Cambrex Recent Developments/Updates
6.5 Pharmaceutics International, Inc
6.5.1 Pharmaceutics International, Inc Company Information
6.5.2 Pharmaceutics International, Inc Description and Business Overview
6.5.3 Pharmaceutics International, Inc Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pharmaceutics International, Inc Sterile Dosage Form Product Portfolio
6.5.5 Pharmaceutics International, Inc Recent Developments/Updates
6.6 Thermo Fisher Scientific
6.6.1 Thermo Fisher Scientific Company Information
6.6.2 Thermo Fisher Scientific Description and Business Overview
6.6.3 Thermo Fisher Scientific Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Thermo Fisher Scientific Sterile Dosage Form Product Portfolio
6.6.5 Thermo Fisher Scientific Recent Developments/Updates
6.7 Curia Global
6.7.1 Curia Global Company Information
6.7.2 Curia Global Description and Business Overview
6.7.3 Curia Global Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Curia Global Sterile Dosage Form Product Portfolio
6.7.5 Curia Global Recent Developments/Updates
6.8 Dec Group
6.8.1 Dec Group Company Information
6.8.2 Dec Group Description and Business Overview
6.8.3 Dec Group Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dec Group Sterile Dosage Form Product Portfolio
6.8.5 Dec Group Recent Developments/Updates
6.9 Grand River Aseptic Manufacturing
6.9.1 Grand River Aseptic Manufacturing Company Information
6.9.2 Grand River Aseptic Manufacturing Description and Business Overview
6.9.3 Grand River Aseptic Manufacturing Sterile Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Grand River Aseptic Manufacturing Sterile Dosage Form Product Portfolio
6.9.5 Grand River Aseptic Manufacturing Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sterile Dosage Form Industry Chain Analysis
7.2 Sterile Dosage Form Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sterile Dosage Form Production Mode & Process Analysis
7.4 Sterile Dosage Form Sales and 麻豆原创ing
7.4.1 Sterile Dosage Form Sales Channels
7.4.2 Sterile Dosage Form Distributors
7.5 Sterile Dosage Form Customer Analysis
8 Sterile Dosage Form 麻豆原创 Dynamics
8.1 Sterile Dosage Form Industry Trends
8.2 Sterile Dosage Form 麻豆原创 Drivers
8.3 Sterile Dosage Form 麻豆原创 Challenges
8.4 Sterile Dosage Form 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Ten23 Health AG
DSM
VxP Pharma
Cambrex
Pharmaceutics International, Inc
Thermo Fisher Scientific
Curia Global
Dec Group
Grand River Aseptic Manufacturing
听
听
*If Applicable.